- Patent Title: IOL with drug delivery devices and uninterrupted PCO barrier edge
-
Application No.: US17540212Application Date: 2021-12-01
-
Publication No.: US11654014B2Publication Date: 2023-05-23
- Inventor: Craig Alan Cable, II , Glenn R. Sussman , James R. Dennewill , Malik Y. Kahook
- Applicant: SpyGlass Pharma, Inc. , The Regents of the University of Colorado, a body corporate
- Applicant Address: US CA Aliso Viejo
- Assignee: SpyGlass Pharma, Inc.,The Regents of the University of Colorado
- Current Assignee: SpyGlass Pharma, Inc.,The Regents of the University of Colorado
- Current Assignee Address: US CA Aliso Viejo; US CO Denver
- Agency: Polsinelli PC
- Main IPC: A61F2/16
- IPC: A61F2/16
Abstract:
An ophthalmic implant including an IOL with haptics, and drug delivery devices secured to the haptics. The posterior-most extent of the drug delivery device is located anterior to the posterior edge or PCE barrier edge, of the IOL. In other configurations, the drug delivery devices are provided with PCO barrier edges.
Public/Granted literature
- US20220104937A1 IOL WITH DRUG DELIVERY DEVICES AND UNINTERRUPTED PCO BARRIER EDGE Public/Granted day:2022-04-07
Information query
IPC分类:
